Noida: The government institute of medical sciences (GIMS) has launched a dedicated screening facility for Retinopathy of Prematurity (ROP), a potentially blinding eye disorder affecting premature and low-birth-weight newborns. Operational since October, the facility has screened 23 babies so far, of whom two required laser treatment to prevent irreversible retinal damage.The screening, conducted every Thursday together with specialists from the retina department of ICARE Eye Hospital, aims at ensuring early detection for high-risk newborns.“ROP occurs when abnormal blood vessels develop in the retina, the light-sensitive tissue at the back of the eye. It primarily affects premature babies whose retinal blood vessels have not fully developed at birth. In severe cases, abnormal vessel growth can lead to retinal detachment and irreversible blindness if treatment is delayed,” said a senior pediatrician at GIMS. The facility also provides treatment for babies diagnosed with sight-threatening ROP.Of the 23 newborns screened since October, two were identified as requiring laser photocoagulation, a procedure used to treat abnormal retinal blood vessel growth and stop ROP.Pediatricians said early screening is crucial because the disease may not produce visible symptoms in its initial stages. Premature babies who appear healthy or have been discharged from neonatal ICUs may develop the condition, too.Under the screening guidelines, babies weighing less than 2kg at birth or born before 34 weeks of gestation are recommended the examination. These infants may also require screening if they have risk factors like prolonged oxygen therapy, respiratory distress syndrome, neonatal sepsis, blood transfusions, chronic lung disease or poor postnatal weight gain.Experts said the first screening for the infants is generally recommended at four weeks. Babies born before 28 weeks of gestation or weighing less than 1.2 kg should undergo their first examination earlier, usually within two to three weeks.Officials advised parents to adhere to follow-up schedules, as the condition can progress even when a newborn appears clinically stable.
